Skip to main content
. 2019 Nov-Dec;35(6):1680–1686. doi: 10.12669/pjms.35.6.771

Fig. 6.

Fig. 6

SUCRA for the cumulative probabilities.

Abbreviations: Placebo: 1, Belimumab: 2, Atacicept: 3, Epratuzumab: 4, Tabalumab: 5, Rituximab: 6, Blisibimod: 7